DOCSLIB.ORG

European Chemicals Bureau

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
European Chemicals Bureau Institute for Health and European List of Notified Consumer Protection Chemical Substances European In support of Chemicals Directive 92/32/EEC, Bureau th the 7 amendment to Directive 67/548/EEC 1 EUR 22543 EN The mission of the IHCP is to provide scientific support to the development and implementation of EU polices related to health and consumer protection. The IHCP carries out research to improve the understanding of potential health risks posed by chemical, physical and biological agents from various sources to which consumers are exposed. The Toxicology and Chemical Substances Unit (TCS), commonly known as the European Chemicals Bureau (ECB), provides scientific and technical input and know-how to the conception, development, implementation and monitoring of EU policies on dangerous chemicals including the coodination of EU Risk Assessments. The aim of the legislative activity of the ECB is to ensure a high level of protection for workers, consumers and the environment against dangerous chemicals and to ensure the efficient functioning of the internal market on chemicals under the current Community legislation. It plays a major role in the implementation of REACH through development of techncial guidance for industry and new chemcials agency and tools for chemcial dossier registration (IUCLID5). The TCS Unit ensures the development of methodologies and software tools to support a systematic and harmonised assessment of chemicals addressed in a number of European directives and regulation on chemcials. The research and support activities of the TCS are executed in close co-operation with the relevant authorities of the EU MS, Commission services (such as DG Environment and DG Enterprise), the chemical industry, the OECD and other international organisations. European Commission Directorate-General Joint Research Centre Institute of Health and Consumer Protection (IHCP) European Chemicals Bureau (ECB) Contact information: Institute of Health and Consumer Protection (IHCP) Address: Via E. Fermi 1 – 21020 Ispra (Varese) – Italy E-mail: [email protected] Tel.: +39 0332 785959 Fax: +39 0332 785730 http://ihcp.jrc.cec.eu.int/ European Chemicals Bureau (ECB) E-mail: [email protected] http://ecb.jrc.it/ Directorate-General Joint Research Centre http://www.jrc.cec.eu.int Legal Notice Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information. A great deal of additional information on the European Union is available on the Internet. It can be accessed through the Europa Server (http://europa.eu.int). EUR 22543 EN ISSN 1018-5593 Luxembourg: Office for Official Publications of the European Communities, 2006 © European Communities, 2006 Reproduction is authorised provided the source is acknowledged. Printed in Italy 2 FOREWORD TO ELINCS Publication In accordance with Commission Decision 85/71/EEC1 [pursuant to Directive 92/32/EEC, the 7th amendment to Directive 67/548/EEC2 (hereinafter "the Directive") on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances] the European LIst of Notified Chemical Substances (ELINCS) has been established with publication in the Official Journal of the European Union (OJ). A 5th edition of ELINCS, compiling substances notified in accordance with the Directive until 30th June 1995, is the last available update published in the OJ3. A 6th edition, comprehensive of substances notified until 30th June 1998, and published in all EU languages as a Commission document, is available on-line via Europa EUR-Lex address: http://europa.eu.int/eur-lex/, located under ‘Documents of public interest’ with reference: COM(2003) 642, dated 29.10.2003. Due to resource limitations on translating chemical names into all official EU languages, ELINCS is currently maintained in English language only, and published only as an internet document via ECB address: http://ecb.jrc.it/new-chemicals/, where the latest update replaces previous versions. Pending any eventual resumption of official printing of further ELINCS updates, the current version is indicated with compilation date, rather than edition number. However, allocation of resources for translation of chemical names, requisite for publication in the OJ, is not currently projected. ELINCS supplements the European INventory of Existing Commercial Substances (EINECS)4, which lists reported substances on the EU market before 18 September 1981. While EINECS is a definitive inventory of substances exempt from notification, ELINCS does not create analogous exemptions. An original notification is generally designated as file leader for the substance. Additional suppliers of notified substances to the EU market are liable to repeat notification, in accordance with the Directive. However, when a substance has already been notified, it is recommended for animal welfare, that the repeat notifier (with approval of a Competent Authority) make reference to assays reported in previous notifications, assuming written agreement from the previous notifier. Explanatory Detail Numbers EC Number (analogous to a bar code) is unique to each substance, allocated by the Commission. Registration Number (chronological per member state) is unique to each notification, allocated by a Competent Authority. For multiple notifications of the same substance, the original dossier is designated file leader. 1 OJ L 30, 2.2.1985, p. 33 2 OJ 196, 16.8.1967, p. 1 [Directive 7th amendment: OJ L 154, 5.6.1992, p. 1] 3 OJ C 72, 11.3.2000, p. 1 4 OJ C 146 A, 15.6.1990, p. 1 3 ELINCS tabulates substances by EC number, corresponding to single substance entries, listing repeat notifications beginning with the file leader. The registration number has standard format: xx-xx-xxxx. The first two digits represent year of notification, the next two indicate country of notification, and the last four digits allow sequential numbering of individual dossiers respective of the country. The two digit country codes refer to member states (and Norway) as follows: 01. France (FR) 10. Greece (GR) 19. Cyprus (CY) 02. Belgium (BE) 11. Spain (ES) 20. Latvia (LV) 03. Netherlands (NL) 12. Portugal (PT) 21. Lithuania (LT) 04. Germany (DE) 13. Finland (FI) 22. Hungary (HU) 05. Italy (IT) 14. Austria (AT) 23. Malta (MT) 06. United Kingdom (UK) 15. Sweden (SE) 24. Poland (PL) 07. Ireland (IE) 16. Norway (NO) 25. Slovenia (SI) 08. Denmark (DK) 17. Czech Rebublic (CZ) 26. Slovakia (SK) 09. Luxembourg (LU) 18. Estonia (EE) Identification Each substance is identified, either by trade name(s) and chemical name, or by trade name(s) only. The latter is applicable when confidentiality has been granted by a Competent Authority, upon request of a notifier, to protect commercial sensitivity. ELINCS includes all trade names registered for a substance. Chemical names are cited according to the rules of the International Union of Pure and Applied Chemistry (IUPAC). Where allocation of a precise IUPAC name is not possible (e.g., substance composition not completely defined), a name is assigned according to EINECS reporting rules (Manual of Decisions section 2). In practice, options are available to notifiers (subject to CA approval) determining level of confidentiality to be respected in publishing substance identities in ELINCS, indicated in notification summaries as follows: Non-Classified substances A. IUPAC name and trade name. B1. Trade name only for period of 1year. B2. Trade name only for period of 2 years. B3. Trade name only for period of 3 years. C. Trade name only for an indefinite period, for reasons of commercial secrecy. Classified substances D. IUPAC name and trade name. E. Trade name only, pending inclusion of substance in Annex I of Directive. 4 Options C and E, respective of non-classified and classified substances, would frequently be favourable choices for notifiers. ELINCS conventions: components versus impurities In general, ‘substance’ refers to a product obtained from a chemical process, which may include distinct components (and/or impurities) present as a reaction mixture. By contrast, ‘preparation’ refers to a blend of substances, integrated in measured proportions. Typically, reaction mixtures would comprise isomers or generically related species as components, while preparations would include solvents or other substances combined as a formulation appropriate for storage, transport, marketing, use application, etc. ELINCS lists substances only. Formulated preparations are not listed. ELINCS defines substance components as molecules present at >10%. An individual molecule present at >80% defines a single component substance, listed as that one molecule name only. Individual molecules present in the range >10% to <80% define components of a reaction mixture substance, listed with all component molecule names. Impurities, defined as individual molecules present at <10%, are not listed in ELINCS unless significant contribution is made to the substance classification. Percentage compositions are obtained by reference to notification summaries prepared using Data Entry Screens (DES) software, so-called SNIF (Structured Notification Interchange Format) files. Classification ELINCS quotes substance classifications from official source only (Annex I to the Directive) with insertion of recent classifications in updated editions, as available from official update of the Annex I list of classified substances. Substances unofficially classified,
Load more

Recommended publications
  • Da UNIVERSIDADE DA BEIRA INTERIOR
    da UNIVERSIDADE DA BEIRA INTERIOR ANALYSIS OF ORGANOPHOSPHOROUS PESTICIDES IN POSTMORTEM BIOLOGICAL FLUIDS RAQUEL HELENA CARVALHO SILVA RAPOSO Covilhã, 2009 I UNIVERSIDADE DA BEIRA INTERIOR ANALYSIS OF ORGANOPHOSPHOROUS PESTICIDES IN POSTMORTEM BIOLOGICAL FLUIDS Dissertação apresentada à Universidade da Beira Interior para a obtenção do Grau de Mestre em Bioquímica RAQUEL HELENA CARVALHO SILVA RAPOSO Covilhã, 2009 II Trabalho elaborado sob a supervisão e orientação científica do Mestre Mário João Dias, Director do Serviço de Toxicolgia Forense da Delegação Sul do Instituto Nacional de Medicina Legal e da Prof. Doutora María Eugenia Gallardo Alba, Faculdade de Ciências da Saúde da Universidade da Beira Interior III TABLE OF CONTENTS List of Figures ........................................................................................................................................... VI List of Tables .......................................................................................................................................... VIII Abbreviations ............................................................................................................................................ X Abstract................................................................................................................................................... - 1 - Resumo ................................................................................................................................................... - 3 - Justification and Objectives
    [Show full text]
  • INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA in a CHLORPYRIFOS RISK ASSESSMENT Julie E
    Dose-Response: An International Journal Volume 11 | Issue 2 Article 8 6-2013 INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT Julie E. Goodman Gradient, Cambridge, MA Robyn L. Prueitt Gradient, Cambridge, MA Lorenz R. Rhomberg Gradient, Cambridge, MA Follow this and additional works at: https://scholarworks.umass.edu/dose_response Recommended Citation Goodman, Julie E.; Prueitt, Robyn L.; and Rhomberg, Lorenz R. (2013) "INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT," Dose-Response: An International Journal: Vol. 11 : Iss. 2 , Article 8. Available at: https://scholarworks.umass.edu/dose_response/vol11/iss2/8 This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. Goodman et al.: Low-Dose Epidemiology Data in a Chlorpyrifos Risk Assessment Dose-Response, 11:207–219, 2013 Formerly Nonlinearity in Biology, Toxicology, and Medicine Copyright © 2013 University of Massachusetts ISSN: 1559-3258 DOI: 10.2203/dose-response.12-022.Goodman INCORPORATING LOW-DOSE EPIDEMIOLOGY DATA IN A CHLORPYRIFOS RISK ASSESSMENT Julie E. Goodman, Robyn L. Prueitt, and Lorenz R. Rhomberg ᮀ Gradient, Cambridge, MA ᮀ USEPA assessed whether epidemiology data suggest that fetal or early-life chlorpyrifos exposure causes neurodevelopmental effects and, if so, whether they occur at exposures below those causing the current most sensitive endpoint, 10% inhibition of blood acetyl- cholinesterase (AChE). We previously conducted a hypothesis-based weight-of-evidence analysis and found that a proposed causal association between chlorpyrifos exposure and neurodevelopmental effects in the absence of AChE inhibition does not have a substantial basis in existing animal or in vitro studies, and there is no plausible basis for invoking such effects in humans at their far lower exposure levels.
    [Show full text]
  • Mother/Child Organophosphate and Pyrethroid Distributions T ⁎ Natalia Bravoa, Joan O
    Environment International 134 (2020) 105264 Contents lists available at ScienceDirect Environment International journal homepage: www.elsevier.com/locate/envint Mother/child organophosphate and pyrethroid distributions T ⁎ Natalia Bravoa, Joan O. Grimalta, , Darja Mazejb, Janja Snoj Tratnikb,c, Dimosthenis Andreas Sarigiannisd, Milena Horvatb,c a Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Department of Environmental Chemistry, Jordi Girona, 18, 08034 Barcelona, Catalonia, Spain b Department of Environmental Sciences, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia c International Postgraduate School Jožef Stefan, Jamova cesta 39, 1000 Ljubljana, Slovenia d Environmental Engineering Laboratory, Department of Chemical Engineering and HERACLES Research Centre on the Exposome and Health, Centre for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki University Campus, Bldg. D, Rm 201, 54124 Thessaloniki, Greece ARTICLE INFO ABSTRACT Handling Editor: Adrian Covaci The present study reports one of the few cases in which organophosphate (OP) and pyrethroid (PYR) pesticide Keywords: human exposure is evaluated in family contexts by the analysis of mother/child pair samples. Urinary con- Organophosphorus pesticides centrations of 6 organic metabolites of organophosphates and 2 pyrethroids were measured in mothers and their Pyrethroids 7-to 8-year-old children (n = 168) in a general population from the central area of Slovenia. The results were Human Biomonitoring adjusted for specific gravity and creatinine. Children The most abundant OP metabolite in children was 4-nitrophenol (PNP) (median 0.7 ng/ml) and in mothers Women (0.45 ng/ml), representing parathion exposure. 3-Phenoxibenzoic acid (3-PBA) (0.26 ng/ml), the general me- Child-mother pairs tabolite of pyrethroids, and 3,5,6-trichloro-2-pyridinol (TCPY) (0.16 ng/ml; chlorpyriphos) were the second most abundant compounds in children and mothers, respectively.
    [Show full text]
  • Part I Biopharmaceuticals
    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
    [Show full text]
  • A10 Anabolic Steroids Hardcore Info
    CONTENTS GENERAL INFORMATION 3 Anabolic steroids – What are they? 4 How do they Work? – Aromatisation 5 More molecules – More problems 6 The side effects of anabolic steroids 7 Women and anabolic steroids 8 Injecting steroids 9 Abscesses – Needle Exchanges 10 Intramuscular injection 11 Injection sites 12 Oral steroids – Cycles – Stacking 13 Diet 14 Where do steroids come from? Spotting a counterfeit 15 Drug Information – Drug dosage STEROIDS 16 Anadrol – Andriol 17 Anavar – Deca-Durabolin 18 Dynabolon – Durabolin – Dianabol 19 Esiclene – Equipoise 20 Primobolan Depot – Proviron – Primobolan orals – Pronobol 21 Sustanon – Stromba, Strombaject – Testosterone Cypionate Testosterone Enanthate 22 Testosterone Propionate – Testosterone Suspension 23 Trenbolone Acetate – Winstrol OTHER DRUGS 24 Aldactone – Arimidex 25 Clenbuterol – Cytomel 26 Ephedrine Hydrochloride – GHB 27 Growth Hormone 28 Insulin 30 Insulin-Like Growth Factor-1 – Human Chorionic Gonadotrophin 31 Tamoxifen – Nubain – Recreational Drugs 32 Steroids and the Law 34 Glossary ANABOLIC STEROIDS People use anabolic steroids for various reasons, some use them to build muscle for their job, others just want to look good and some use them to help them in sport or body building. Whatever the reason, care needs to be taken so that as little harm is done to the body as possible because despite having muscle building effects they also have serious side effects especially when used incorrectly. WHAT ARE THEY? Anabolic steroids are man made versions of the hormone testosterone. Testosterone is the chemical in men responsible for facial hair, deepening of the voice and sex organ development, basically the masculine things Steroids are in a man. used in medicine to treat anaemia, muscle weakness after These masculine effects surgery etc, vascular are called the androgenic disorders and effects of testosterone.
    [Show full text]
  • Miss.Julie ^ ^ Email:[email protected] Skype:[email protected] Whatsapp:+8618872220730
    Miss.Julie ^ _ ^ Email:[email protected] Skype:[email protected] Whatsapp:+8618872220730 Raw anabolic steroid hormone powders from China with high purity&safe delivery Powder list : Testosterone enanthate Testosterone cypionate Testosterone propionate Testosterone-Sustanon250 Testosterone phenylpropionate Testosterone Acetate Testosterone decanoate Testosterone-Base Testosterone Isocaproate Testosterone undecanoate 17a-Methyl-1-Testosterone Fluoxymesterone(Halotesin) Mesterolone(Proviron) Methyltestosterone Trenbolone Acetate Trenbolone enanthate Trenbolone Base Metribolone Trenbolone Hexahydrobenzyl Carbonate Nandrolone decanoate Nandrolone Propionate Nandrolone phenylpropionate Nandrolone Mestanolone Drostanolone enanthate Drostanolone propionate (Masteron) 17a-Methyl-Drostanolone (Methasterone) Boldenone undecylenate (EQ) Methenolone Acetate Methenolone Enanthate (primobolin) Boldenoe cypionate Boldenoe Acetate Methandrostenolone (Dianabol) Oxandrolone (Anavar) Oxymetholone (Anadrol) Stanozolol (Winstrol) Turinabol Clostebol Acetate Anastrozloe (Arimidex) Clomiphene Citrate(Clomid) Exemestane Letrozole (Femara) Mifepristone Tamoxifen Citrate Semi-finished Injectable / Oral steroids: Test prop-----------100mg/ml 200mg/ml Test enan-----------250mg/ml 300mg/ml 400mg/ml 500mg/ml 600mg/ml Test cyp------------200mg/ml 250mg/ml 300mg/ml Test Sustanon-------200mg/ml 250mg/ml 300mg/ml 400mg/ml Deca----------------200mg/ml 250mg/ml Equipoise-----------200mg/ml 300mg/ml Tren ace------------100mg/ml 200mg/ml Tren enan-----------100mg/ml
    [Show full text]
  • Estimation of Daily Intake and Risk Assessment of Organophosphorus Pesticides Based on Biomonitoring Data
    Food and Chemical Toxicology 123 (2019) 57–71 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Review Estimation of daily intake and risk assessment of organophosphorus T pesticides based on biomonitoring data – The internal exposure approach Ioanna Katsikantamia,b, Claudio Colosioc, Athanasios Alegakisb, Manolis N. Tzatzarakisb, ∗ Elena Vakonakib, Apostolos K. Rizosa, Dimosthenis A. Sarigiannisd,e,f, Aristides M. Tsatsakisb, a Department of Chemistry, University of Crete, Foundation for Research and Technology-Hellas, FORTH-IESL, GR-71003, Heraklion, Crete, Greece b Laboratory of Toxicology, Medical School, University of Crete, GR-71003, Heraklion, Crete, Greece c Department of Occupational and Environmental Health of the University of Milan, International Centre for Rural Health of the University Hospital San Paolo, S. Paolo Hospital Unit, Via San Vigilio 43, 20142 Milan, Italy d Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Greece e HERACLES Research Centre on the Exposome and Health, Centre for Interdisciplinary Research and Innovation (KEDEK), Aristotle University of Thessaloniki, Greece f Environmental Health Engineering, Institute for Advanced Study IUSS, Pavia, Italy ARTICLE INFO ABSTRACT Keywords: Human exposure to pesticides can be estimated through different approaches. The approach adopted in this Biomonitoring study is based on internal dose measures. Studies published during 2001 and 2017 were collected from PubMed Dialkyl phosphates and Scopus databases, filtered and organized. The intake of parent compounds is estimated based on theurinary Estimated daily intake excretion of different OP metabolites applying a mathematical model previously used for similar purposes. Once Health effects defined an Estimated Daily Intake (EDI), risk assessment is performed through comparison with specific Organophosphorus pesticides guideline values and hazard index (HI) is calculated to assess cumulative health risk.
    [Show full text]
  • Winter 2007–2008
    Pesticides and You News from Beyond Pesticides: Protecting Health and the Environment with Science, Policy and Action Volume 27, Number 4 Winter 2007-2008 Facing Scientifi c Realities, Debunking the “Dose Makes the Poison” Myth How Safe is Your Bait? Pesticides May Be Labeled as “Nonvolatile,” But Still Release Poisons into the Air Grounding out Grubs: Managing grubs with prevention and least-toxic strategies The Secret History of the War on Cancer Letter from Washington Danger at (Really) Low Dose Mo�vates changes that reject the use of toxic chemicals arm resul�ng from really low dose exposure to toxic chemicals can be measured in the air, with the excep�on of boric acid, which is now accepted in scien�fic circles. However, the pes�cide is commonly found in bait formula�ons. With the science on low Hregulatory process s�ll does not reflect the science, nor does level exposure and poten�al adverse impact, we know why there it comply with a 1996 statutory requirement that the agency have ought to be concern, especially when the chemical is placed for long in place by now a protocol for evalua�ng pes�cides that may be periods in and around the perimeter of a room in a sealed indoor endocrine disruptors, known to wreak havoc at miniscule doses in environment. Our ar�cle sheds some important light on this topic. developing organ systems. More data emerges year by year. When we do not have all the answers Lab experiments link exposure to brain effects This discussion adds important weight to the already heavy support In this issue of PAY, we print a talk given by Warren Porter, Ph.D., for the precau�onary approach to pest management.
    [Show full text]
  • United States Patent (10) Patent No.: US 7,790,910 B2 Macdonald Et Al
    US007790910B2 (12) United States Patent (10) Patent No.: US 7,790,910 B2 MacDonald et al. (45) Date of Patent: Sep. 7, 2010 (54) PROCESS FOR THE PREPARATION OF 2003/0069434 A1 4/2003 Bohlmann et al. 7OALKYLATED 19-NORSTEROIDS 2005, OO33085 A1 2/2005 Warren et al. (75) Inventors: Peter Lindsay MacDonald, Gentilino FOREIGN PATENT DOCUMENTS (CH); Ettore Bigatti, Balerna (CH): DE 24, 29 O40 1, 1975 Pierluigi Rossetto, Balerna (CH) DE 19622 457 11, 1997 EP O138504 T 1988 (73) Assignee: Sicor Inc., Irvine, CA (US) WO WO93/10741 6, 1993 WO WO99/33855 * 7/1999 (*) Notice: Subject to any disclaimer, the term of this WO WO99,42109 8, 1999 patent is extended or adjusted under 35 WO WOO2,32922 4/2002 U.S.C. 154(b) by 1427 days. WO WOO3,O31399 4/2003 WO WOO3,O45972 6, 2003 (21) Appl. No.: 11/192,071 WO WO98,07740 T 2003 (22) Filed: Jul. 27, 2005 OTHER PUBLICATIONS Bucourt, et al., “New Biospecific Adsorbents For The Purification Of (65) Prior Publication Data Estradiol Receptor'. Journal of Biological Chemistry, 1978, pp. 8221-8228, vol. 253, No. 22. US 2006/OO30552 A1 Feb. 9, 2006 Dasilva, et al., “Synthesis And Structure-Affinity Of A Series of 7alpha-Undecylestradiol Derivatives: A Potential Vector For Related U.S. Application Data Therapy And Imaging Of Estrogen-Receptor-Positive Cancers'. Journal of Medicinal Chemistry, 1990, pp. 430-434, vol. 33, No. 1. (60) sy, priat e.sfas: A.i Skaddan, et al., “Synthesis And Binding Affinities Of Novel Re s proV1S1ona application o, o s , Ille Containing 7.Alpha.-Substituted Estradiol Complexes: Models For on Aug.
    [Show full text]
  • Impact of Urine Preservation Methods and Duration of Storage on Measured Levels of Environmental Contaminants
    Journal of Exposure Science and Environmental Epidemiology (2006) 16, 39–48 r 2006 Nature Publishing Group All rights reserved 1559-0631/06/$30.00 www.nature.com/jes Impact of urine preservation methods and duration of storage on measured levels of environmental contaminants JANE A. HOPPIN,a ROSS ULMER,b ANTONIA M. CALAFAT,c DANA B. BARR,c SUSAN V. BAKER,d HELLE M. MELTZERe AND KJERSTI S. RØNNINGENe aEpidemiology Branch, NIEHS, NIH, DHHS, Research Triangle Park, North Carolina, USA bWestat, Research Triangle Park, North Carolina, USA cNational Center for Environmental Health, Centers for Disease Control and Prevention, DHHS, Atlanta, Georgia, USA dCODA Research, Research Triangle Park, North Carolina, USA eNorwegian Institute of Public Health, Oslo, Norway Collection of urine samples in human studies involves choices regarding shipping, sample preservation, and storage that may ultimately influence future analysis. As more studies collect and archive urine samples to evaluate environmental exposures in the future, we were interested in assessing the impact of urine preservative, storage temperature, and time since collection on nonpersistent contaminants in urine samples. In spiked urine samples stored in three types of urine vacutainers (no preservative, boric acid, and chlorhexidine), we measured five groups of contaminants to assess the levels of these analytes at five time points (0, 24, 48, and 72 h, and 1 week) and at two temperatures (room temperature and 41C). The target chemicals were bisphenol A (BPA), metabolites of organophosphate (OP), carbamate, and pyrethroid insecticides, chlorinated phenols, and phthalate monoesters, and were measured using five different mass spectrometry-based methods. Three samples were analyzed at each time point, with the exception of BPA.
    [Show full text]
  • Appendix A: Metabolism
    DRAFT Appendix A: Metabolism August 21, 2008 Prepared by: Health Effects Division Office of Pesticide Programs US Environmental Protection Agency Page 1 of 82 DRAFT TABLE OF CONTENTS 1. Introduction. ............................................................................................................ 5 2. Metabolism in Adult Animals................................................................................... 7 3. In Vitro Metabolism of Chlorpyrifos ....................................................................... 14 3.1. Cytochrome P450 (The CYP Enzymes)........................................................ 14 3.2. The PON1 Enzyme....................................................................................... 24 3.3. B-Esterases (Carboxylesterases) ................................................................. 27 3.4. Glutathione S-transferases ........................................................................... 28 3.5. KIAA1363 – A Mouse Brain Enzyme ............................................................ 31 3.6. Role of Butyrylcholinesterase in Chlorpyrifos Metabolism ............................ 32 4. Metabolism in Neonatal Animals........................................................................... 33 4.1. Metabolism and Toxicokinetic Studies in Pregnant Dams, Fetuses, and Post- Natal Pups .................................................................................................... 33 4.2. Gestational Exposure (GD14-18): Measurement of TCP in rat maternal and fetal brain and
    [Show full text]
  • Biomarker Review and Development Strategy.Pdf
    INTARESE Project No. 018385 INTARESE Integrated Assessment of Health Risks of Environmental Stressors in Europe Integrated Project Thematic Priority Deliverable 20: Biomarker review and development strategy (WP 2.2) Due date of deliverable: 05/2007 Actual submission date: 06/2007 Start Date of Project: 1 November 2005 Duration: 60 Months Organisation name of lead contractor for this deliverable: VITO Revision: Final version Project co-funded by the European Commission with the Sixth Framework Programme (2002- 2006) Dissemination Level PU Public PP Restricted to other programme participants (including the Commission Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services Table of content 1 A brief introduction to human biomonitoring ............................................................... 2 2 Alkylphenols ............................................................................................................... 7 3 Alpha1-microglobulin (α1-m) ..................................................................................... 20 4 Arsenic ...................................................................................................................... 23 5 β2-microglobulin (β2-m) ............................................................................................ 34 6 Bisphenol A .............................................................................................................
    [Show full text]